Tonix Pharmaceuticals Holding Corp (LTS:0A4T) Stock News, Headlines & Updates
Tonix Pharmaceuticals Holding Corp Stock News from GuruFocus
- 1
Jun 20, 2024
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmyaâ„¢ for the Management of Fibromyalgia
Marketwired • 7:00am
Jun 18, 2024
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
Marketwired • 7:00am
Jun 17, 2024
Tonix Pharmaceuticals Presented Poster of Tonmyaâ„¢ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024
Marketwired • 7:00am
Jun 13, 2024
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
Marketwired • 4:00pm
Jun 12, 2024
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
Marketwired • 8:00am
Jun 11, 2024
Tonix Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire • 5:00pm
Tonix Pharmaceuticals Announces Proposed Public Offering
Marketwired • 5:00pm
Jun 06, 2024
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
Marketwired • 10:00am
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024
Marketwired • 7:00am
Jun 05, 2024
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024
Marketwired • 7:00am
Jun 03, 2024
Tonix Pharmaceuticals Presented New Data on Tonmyaâ„¢ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
Marketwired • 7:00am
May 30, 2024
Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting
Marketwired • 7:00am
May 29, 2024
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024
Marketwired • 7:00am
May 28, 2024
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
Marketwired • 7:00am
May 22, 2024
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Marketwired • 7:00am
May 21, 2024
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmyaâ„¢ for the Management of Fibromyalgia
Marketwired • 7:00am
May 15, 2024
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Marketwired • 7:00am
May 13, 2024
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
Marketwired • 4:00pm
Apr 24, 2024
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news